Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Effexor Lawsuit Alleges Baby Born with Heart Problems Caused by the Antidepressant Drug
  • USA - English


News provided by

Wright & Schulte LLC

May 12, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Effexor Lawsuit Alleges Baby Born With Heart Problems Caused By The Antidepressant Drug
Effexor Lawsuit Alleges Baby Born With Heart Problems Caused By The Antidepressant Drug

Wright & Schulte LLC offers free legal evaluations to those who believe their child suffered a heart malformation or some other birth defect from SSRIs such as Effexor, Zoloft and Paxil. Visit www.yourlegalhelp.com or call 1-800-399-0795

Post this

Columbus, OH (PRWEB) May 12, 2014 -- An Effexor lawsuit was filed by Wright & Schulte LLC on behalf of an Ohio woman whose child was born with birth defects allegedly because she took the SSRI antidepressant drug Effexor while she was pregnan t. This Effexor lawsuit was filed in the U.S. District Court, Northern District of Ohio against Pfizer Inc., J.B. Roerig & Company, a subsidiary of Pfizer Inc., and Wyeth Pharmaceuticals Inc., another Pfizer, Inc. subsidiary. (Case No. 1:14-cv-204). The mother alleges in her Effexor complaint that her baby was born with a complex congenital heart defect known as tetralogy of Fallot, a hole in the heart, also called patent foramen ovale, and other congenital heart conditions which caused her son to undergo multiple surgeries and other medical procedures.

The SSRI antidepressant lawsuit contends that the defendants knew or should have known that Effexor crosses the placenta and poses significant risks to a developing fetus, resulting in babies being born with congenital birth defects. The mother further contends in her Effexor complaint that had she known the actual facts about the antidepressant drug, she would not have taken the medication while she was pregnant.

Our firm continues to speak with mothers and fathers whose babies are sadly born with birth defects purportedly due to Effexor and other anti-depressant drugs. Our Effexor attorneys will defend your rights and fight for the compensation you deserve. For a free Effexor lawsuit evaluation, call Wright & Schulte LLC at 1-800-399-0795 or visit http://www.yourlegalhelp.com

Effexor, also known as venlafaxine hydrochloride, falls into the selective serotonin/norepinephrine reuptake inhibitor classification of drugs that has been approved by the U.S. Food & Drug Administration (FDA) to treat depression, anxiety, and other mood disorders. According to the FDA, Effexor and other prescription antidepressant drugs may have serious side effects, such as anxiety, insomnia, an increase in blood pressure, manic or hypomanic episodes, low salt levels in the blood, and an increase of suicidal thoughts or actions in some children, teenagers or young adults within the first few months of treatment or when the dose is changed. Antidepressant medication also poses a serious risk of causing birth defects in women who take the prescription medication during pregnancy, the FDA stated in a December 2013 Consumer Update. Other SSRI anti-depressant drugs include; Aoloft, Lecapro, Paxil, Celexa, and Prozac. [fda.gov/downloads/Drugs/DrugSafety/ucm088586.pdf]
[fda.gov/drugs/drugsafety/ucm283375.htm, December 2011]
[fda.gov/ForConsumers/ConsumerUpdates/ucm095980.htm, December 7, 2013]

Court records indicate the U.S. Judicial Panel on Multidistrict Litigation (JPML) ordered all pending Effexor lawsuits filed against Pfizer Inc., and Wyeth Pharmaceuticals Inc., to be transferred to the U.S. District Court, Eastern District of Pennsylvania for coordinated pretrial hearings. In its August 2013 order to consolidate the cases, the JPML maintained that the pending Effexor complaints share factual questions stemming from allegations that taking the prescription medication during pregnancy cause children to be born with birth defects. (In Re: Effexor (Venlafaxine Hydrochloride) Products Liability Litigation–MDL No. 2458)

According to the JPML’s Litigation Statistics report, there are 54 Effexor cases pending in the federal court in Pennsylvania, as of April 15, 2014. The judicial panel stated in its transfer order that U.S. District Judge Cynthia M. Rufe will oversee the Effexor cases since she is already managing multidistrict litigation with similar claims against Pfizer Inc., and Wyeth Pharmaceuticals Inc., over Zoloft, an antidepressant drug that plaintiffs allege causes birth defects in children when taken during pregnancy. (In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation–MDL No. 2342).

Wright & Schulte LLC is representing alleged victims of anti-present medications such as Effexor or venlafaxine hydrochloride in birth defect claims that have been filed in the Southern District of West Virginia, and continues to offer free legal consult. Learn more by visiting yourlegalhelp.com or by calling 1-800-399-0795.

About Wright & Schulte LLLC
Wright & Schulte LLC, an experienced personal injury firm, is dedicated to the belief that America’s legal system should work for the people. Every day, the attorneys of Wright & Schulte LLC stand up for the rights of people who have been injured or wronged and fight tirelessly to ensure that even the world’s most powerful corporations take responsibility for their actions. If you’re looking for a law firm that will guarantee the aggressive and personal representation you deserve, please do not hesitate to contact Wright & Schulte LLC today. Free case evaluations are available through yourlegalhelp.com or by calling 1-800-399-0795.

Contact:
Wright & Schulte LLC
812 East National Road
Vandalia, Ohio 45377
1-800-399-0795
Like us on Facebook
Follow us on Twitter
Join us on Google+

Richard Schulte, Wright & Schulte LLC, http://www.yourlegalhelp.com, +1 1-800-399-0795, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.